We are live on ! Find out more
ITOS

iTeos Therapeutics
ITOS

Delisted

ITOS was delisted on the 28th of August, 2025.

Back to rankings

1 hedge funds and large institutions have $2.35K invested in iTeos Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 135 closing their positions.

New
Increased
Maintained
Reduced
Closed

98.8% less ownership

Funds ownership: 98.8% → 0% (-99%)

99% less funds holding

Funds holding: 136 → 1 (-135)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $377M → $2.35K (-$377M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 135

Holders
1
Holders Change
-135
Holders Change %
-99.26%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
135
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$20

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$107M
2
BlackRock
BlackRock
New York
-$45.6M
3
TCM
Tang Capital Management
California
-$38.2M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$16.6M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$8.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
51
Bank of New York Mellon
New York
– -$773K -77,547 Closed
DTL
52
Dynamic Technology Lab
Singapore
– -$771K -77,371 Closed
AG
53
Algert Global
California
– -$743K -74,477 Closed
CCIA
54
Campbell & Co Investment Adviser
Maryland
– -$720K -72,262 Closed
HSBC Holdings
55
HSBC Holdings
United Kingdom
– -$686K -68,533 Closed
SFI
56
Susquehanna Fundamental Investments
Pennsylvania
– -$666K -66,779 Closed
FIA
57
FNY Investment Advisers
New York
– -$648K -65,000 Closed
EGM
58
Engineers Gate Manager
New York
– -$594K -59,559 Closed
Man Group
59
Man Group
United Kingdom
– -$586K -58,768 Closed
RCM
60
Regency Capital Management
Hawaii
– -$578K -58,000 Closed
Thrivent Financial for Lutherans
61
Thrivent Financial for Lutherans
Minnesota
– -$563K -56,556 Closed
Fisher Asset Management
62
Fisher Asset Management
Washington
– -$556K -55,722 Closed
KK
63
KLP Kapitalforvaltning
Norway
– -$552K -55,400 Closed
CC
64
Clearline Capital
New York
– -$548K -55,013 Closed
D.E. Shaw & Co
65
D.E. Shaw & Co
New York
– -$533K -53,432 Closed
Fidelity Investments
66
Fidelity Investments
Massachusetts
– -$526K -52,740 Closed
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
– -$487K -48,882 Closed
State of Wisconsin Investment Board
68
State of Wisconsin Investment Board
Wisconsin
– -$480K -48,096 Closed
PAP
69
Persistent Asset Partners
Hong Kong
– -$474K -47,512 Closed
IC
70
IEQ Capital
California
– -$453K -45,399 Closed
UBS Group
71
UBS Group
Switzerland
– -$442K -44,288 Closed
AllianceBernstein
72
AllianceBernstein
Tennessee
– -$440K -44,180 Closed
Prudential Financial
73
Prudential Financial
New Jersey
– -$427K -42,861 Closed
OAM
74
Oxford Asset Management
United Kingdom
– -$416K -41,771 Closed
Citigroup
75
Citigroup
New York
– -$396K -39,742 Closed
1 2
3
4 5

ITOS Hedge Fund Activity: Q3 2025 in Review

1 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in iTeos Therapeutics (ITOS) for Q3 2025, worth a combined $2.35K — down 100% from $377M a quarter earlier.

Sellers outnumbered buyers: 135 funds closed out of ITOS and 0 opened new positions — a net loss of 135 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was IFP Advisors, adding an estimated $20. The largest seller was EcoR1 Capital, exiting entirely with an estimated $107M sold.

  • 1 institutional investor held iTeos Therapeutics (ITOS) as of Q3 2025, down from 136 in Q2 2025.
  • Funds reported $2.35K of iTeos Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new iTeos Therapeutics positions in Q3 2025 and 135 closed out, a net change of -135 holders.
  • The largest iTeos Therapeutics buyer in Q3 2025 was IFP Advisors, an estimated $20 added.
  • The largest iTeos Therapeutics seller in Q3 2025 was EcoR1 Capital, an estimated $107M sold.

Based on aggregated 13F filings for Q3 2025.